Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET statusXue‐Ning Shen, Caileigh Zimmerman, Yuyuan Huang et al.|Translational Psychiatry|2021Cited by 70
Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal studyShi-Dong Chen, Michael S. Rafii, Jiaying Lu et al.|Translational Psychiatry|2021Cited by 69
Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysisDiana I. Bocancea, Anna L. Svenningsson, Anna C. van Loenhoud et al.|Brain|2023Cited by 52
White Matter Abnormalities and Cognition in Aging and Alzheimer DiseaseChristopher Peter, Haley Bernhardt, Leslie S. Gaynor et al.|JAMA Neurology|2025Cited by 41
The Alzheimer's Disease Neuroimaging Initiative‐4 (ADNI‐4) Engagement Core: A culturally informed, community‐engaged research (CI‐CER) model to advance brain health equityMónica Rivera Mindt, Alyssa Arentoft, Amanda T. Calcetas et al.|Alzheimer s & Dementia|2024Cited by 22